Pure Global

Cutting-edge medical methamphetamine/ecstasy rapid test reagent - Taiwan Registration 3aaa9ac283af64af96f57818a1b691d6

Access comprehensive regulatory information for Cutting-edge medical methamphetamine/ecstasy rapid test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3aaa9ac283af64af96f57818a1b691d6 and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
3aaa9ac283af64af96f57818a1b691d6
Registration Details
Taiwan FDA Registration: 3aaa9ac283af64af96f57818a1b691d6
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Cutting-edge medical methamphetamine/ecstasy rapid test reagent
TW: ๅฐ–็ซฏ้†ซ ็”ฒๅŸบๅฎ‰้žไป–ๅ‘ฝ/ๆ–้ ญไธธๅฟซ้€Ÿๆชข้ฉ—่ฉฆๅŠ‘
Risk Class 2

Registration Details

3aaa9ac283af64af96f57818a1b691d6

Company Information

Taiwan, Province of China

Product Details

This product uses competitive immunochromatography to qualitatively detect methamphetamine/ecstasy in human urine, and the test results can be used for preliminary screening. The threshold standard for methamphetamine/ecstasy is 500 ng/ml. This product can be used by both individuals and professionals.

A Clinical chemistry and clinical toxicology

A.3610 Methamphetamine testing system

Domestic;; Contract manufacturing

Dates and Status

Oct 03, 2018

Aug 06, 2028